about
Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomesApoptosis and the airway epitheliumPretransplant antithymocyte globulin has increased efficacy in controlling donor-reactive memory T cells in miceHSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized mice.Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoireInduction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen.IL-6 induced by Staphylococcus aureus infection prevents the induction of skin allograft acceptance in mice.Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantationClinical operational tolerance after renal transplantation: current status and future challenges.The immunobiology of Guillain-Barré syndromes.Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.Hematopoiesis from human embryonic stem cells: overcoming the immune barrier in stem cell therapies.Risk Stratification for Rejection and Infection after Kidney Transplantation.Vascularized composite allograft rejection is delayed by intrajejunal treatment with donor splenocytes without concomitant immunosuppressantsImmunoregulatory CD4(-)CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer.Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells.Development and in vitro characterization of canine CD40-Ig.Tolerance to MHC class II disparate allografts through genetic modification of bone marrow.Skin tolerance: in search of the Holy Grail.Long-term control of alloreactive B cell responses by the suppression of T cell help.Rapid deletional peripheral CD8 T cell tolerance induced by allogeneic bone marrow: role of donor class II MHC and B cellsThe role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors.Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft.TLR agonists prevent the establishment of allogeneic hematopoietic chimerism in mice treated with costimulation blockade.Depleting T-cell subpopulations in organ transplantation.Alloreactive CD8 T cell tolerance requires recipient B cells, dendritic cells, and MHC class II.Cryopreservation and the age of the allotransplantRole of bacterial infections in allograft rejection.Role of Toll-like receptors in transplantation tolerance.Immune responses in transplantation: application to composite tissue allograft.Current challenges and future directions for liver transplantation.Role of Memory T Cells in Allograft Rejection and TolerancePancreatic transplantation at the University of Pittsburgh.Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients.Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance.Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies.Patients' motives for consenting or refusing to participate in a clinical trial in organ transplantation.Density dependent re-tuning of autoreactive T cells alleviates their pathogenicity in a lymphopenic environment.
P2860
Q28080994-3BDF9132-8982-44D3-B61E-29D329A56CF1Q28741414-668D173A-2B8A-449C-BCBC-7804DF2F89A3Q33581995-AD752565-6E12-456C-9CFE-98D317D4A0ACQ34204696-F78D936A-60BD-4DBF-8F8C-39514ECA4989Q34245381-2CB4DF4F-9A67-4A15-9C32-0845C3526ADDQ34346825-1FC76B62-0278-492A-80FF-5F829AE3CB58Q34873028-D8927012-742F-47D5-BC3F-98D7357B58D5Q35085385-7A9F0E7B-0A8F-4991-90B7-B2585FBABC2DQ35991484-481D3A1B-539C-4462-B5C7-7F961F2DDE21Q36164122-ACF668EF-FD5D-4D6B-B638-2C42987CCC8FQ36221386-7BEBFB78-DEC6-4A40-82B5-B4C3D27CF343Q36321463-E2813DDE-4304-4E1E-A5E7-2AD1D06FD9DAQ36349405-5ADEDA34-3ABF-4003-B4B7-C5419AF5DD1CQ36446797-06166083-BF8D-413F-A7ED-594258F4A2E2Q36557519-37B3A2EA-128C-4713-9C4D-C650718E023CQ36724788-697B46CD-7ECB-4F01-B9E3-3E9A3309D104Q36772201-02687C13-E40D-4C89-B0F9-EEC84E7AC696Q36836700-19C05CD6-BAAB-4331-9009-C347E9311FCDQ36954616-F31B0523-35C3-4A75-9121-D307115CBCCFQ37019740-D6039547-0B40-4C47-847F-EC2987FD397AQ37066662-A6C16A3B-D1CE-45D3-880A-01A38720D008Q37185367-6AA7A238-5BF7-4E16-BC61-2994AD9138F1Q37203108-7C3AA543-53F2-4097-B5AA-40D32D90C0E7Q37290406-88F106C7-17EC-49CD-B7B3-33A8661B7333Q37316082-DAA09208-6629-4B8E-A0A6-8F9C63B02827Q37324329-5313100B-11FD-44D4-8C7A-7BDCB6361FE2Q37429916-4D391389-58FF-4CCB-A6B1-633868506CB6Q37754716-662A1A44-DBC7-4A13-83AD-50C0D8820C69Q37754767-A6224088-E953-4A2E-BC33-FE9B5F0A64A6Q37766767-F8F0B488-4596-497F-911B-0A0B77C8B868Q38820685-AC166EDC-7283-4C50-A30C-90E9D41B2567Q39178547-A369E4E5-D52F-4668-B9F2-85585C5CFCA8Q41785260-37C42958-9D94-4B5F-9D35-6714686DE156Q42039485-AE68B7CF-67B3-4DEC-A1F6-42029C25D336Q42440224-B1414887-1295-4BDD-89DF-29D92FCAE858Q45875615-6D31CBF5-996C-46F8-864A-FF54B45EFD9FQ47621660-F17FE1D7-A9AA-4337-9185-6AA20C140D6FQ50126510-7AD5C209-7978-4A5F-9FF0-5F7356A689B6
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Tolerance induction in clinical transplantation.
@ast
Tolerance induction in clinical transplantation.
@en
type
label
Tolerance induction in clinical transplantation.
@ast
Tolerance induction in clinical transplantation.
@en
prefLabel
Tolerance induction in clinical transplantation.
@ast
Tolerance induction in clinical transplantation.
@en
P1476
Tolerance induction in clinical transplantation.
@en
P2093
Megan Sykes
Thomas Fehr
P304
P356
10.1016/J.TRIM.2004.05.009
P577
2004-09-01T00:00:00Z